Search - tctmd.com

Displaying 301 - 311 of 311

Sort: Relevancy | Date

News Industry News

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

February 16, 2011

News Industry News

CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients

February 02, 2011

News Industry News

Corindus Vascular Robotics Announces FDA Conditional Approval for Pivotal Study to Evaluate Robotic-Assisted Placement of Coronary Guidewires and Stent-Balloon Catheters

January 25, 2011

News Industry News

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

January 23, 2011

News Industry News

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

January 18, 2011

News Industry News

Boston Scientific to Acquire Atritech

January 18, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

News Industry News

Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

January 09, 2011

News Industry News

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

January 09, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

News Industry News

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

January 02, 2011

Advertisement

Boston Scientific Launches PROMUS® Element™ and TAXUS® Element™ Stent Systems in India

CardioVascular BioTherapeutics Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients

Corindus Vascular Robotics Announces FDA Conditional Approval for Pivotal Study to Evaluate Robotic-Assisted Placement of Coronary Guidewires and Stent-Balloon Catheters

Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY™ Drug-Eluting Coronary Stent

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

Boston Scientific to Acquire Atritech

Merck Statement on Changes to Clinical Studies of Vorapaxar

Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Juventas Therapeutics Initiating Phase II Clinical Trial of JVS-100 for Treatment of Critical Limb Ischemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content